EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Why Don’t the Mutant Cells That Evade DNA Repair Cause Cancer More Frequently? Importance of the Innate Immune System in the Tumor Microenvironment

Shubhasmita Mohapatra, Jared Cafiero, Khosrow Kashfi iD, Parag Mehta, Probal Banerjee

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24055026 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Shubhasmita Mohapatra und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, The College of Staten Island, City University of New York, Staten Island, NY 10314, USA. Hauptthemen laut MEDLINE: Tumor Microenvironment, Brain Neoplasms, Glioblastoma, Immunity, Innate. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The standard of care for most malignant solid tumors still involves tumor resection followed by chemo- and radiation therapy, hoping to eliminate the residual tumor cells. This strategy has been successful in extending the life of many cancer patients. Still, for primary glioblastoma (GBM), it has not controlled recurrence or increased the life expectancies of patients. Amid such disappointment, attempts to design therapies using the cells in the tumor microenvironment (TME) have gained ground. Such “immunotherapies” have so far overwhelmingly used genetic modifications of Tc cells (Car-T cell therapy) or blocking of proteins (PD-1 or PD-L1) that inhibit Tc-cell-mediated cancer cell elimination. Despite such advances, GBM has remained a “Kiss of Death” for most patients. Although the use of innate immune cells, such as the microglia, macrophages, and natural killer (NK) cells, has been considered in designing therapies for cancers, such attempts have not reached the clinic yet. We have reported a series of preclinical studies highlighting strategies to “re-educate” GBM-associated microglia and macrophages (TAMs) so that they assume a tumoricidal status. Such cells then secrete chemokines to recruit activated, GBM-eliminating NK cells and cause the rescue of 50–60% GBM mice in a syngeneic model of GBM. This review discusses a more fundamental question that most biochemists harbor: “since we are generating mutant cells in our body all the time, why don’t we get cancer more often?” The review visits publications addressing this question and discusses some published strategies for re-educating the TAMs to take on the “sentry” role they initially maintained in the absence of cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentBrain NeoplasmsGlioblastomaImmunity, InnateMicrogliaMacrophagesLeukemoid ReactionMiceAnimalsImmunotherapyDNA RepairDown Syndrome

Stichwörter der Autor:innen

chemokinesglioblastomaimmunotherapymacrophagesrepolarizationtumor microenvironment

Autor:innen und Institutionen

  • Department of Chemistry, The College of Staten Island, City University of New York, Staten Island, NY 10314, USA.
  • Department of Molecular, Cellular and Biomedical Sciences, Sophie Davis School of Biomedical Education, City University of New York School of Medicine, New York, NY 10031, USA.
  • Graduate Program in Biology, City University of New York Graduate Center, New York, NY 10016, USA.
  • Aveta Biomics, Inc., 110 Great Road, Suite 302, Bedford, MA 01730, USA.

ORCID-Profile: Khosrow Kashfi

Förderung

  • NIGMS NIH HHS
  • NCI NIH HHS
  • NIH HHS
  • NCI
  • CUNY University Committee on Research Awards
  • National Institutes of Health
  • Professional Staff Congress-City University of New York

Zitieren

APA

Mohapatra, S., Cafiero, J., Kashfi, K., Mehta, P., & Banerjee, P. (2023). Why Don’t the Mutant Cells That Evade DNA Repair Cause Cancer More Frequently? Importance of the Innate Immune System in the Tumor Microenvironment. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24055026

Vancouver

Mohapatra S, Cafiero J, Kashfi K, Mehta P, Banerjee P. Why Don’t the Mutant Cells That Evade DNA Repair Cause Cancer More Frequently? Importance of the Innate Immune System in the Tumor Microenvironment. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24055026

BibTeX
@article{Mohapatra2023,
  author = {Mohapatra, Shubhasmita and Cafiero, Jared and Kashfi, Khosrow and Mehta, Parag and Banerjee, Probal},
  title = {Why Don’t the Mutant Cells That Evade DNA Repair Cause Cancer More Frequently? Importance of the Innate Immune System in the Tumor Microenvironment},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24055026}
}
Kostenlos starten →